300233 金城醫藥
按盤價 
15.590 +0.490 (+3.245%)
15.590 +0.490 (+3.245%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 0.851 | 5.261 | 4.772 | 7.808 | 3.161 |
| 總資產報酬率 ROA (%) | 0.588 | 3.416 | 2.976 | 4.925 | 2.102 |
| 投入資產回報率 ROIC (%) | 0.711 | 4.234 | 3.773 | 6.180 | 2.558 | 邊際利潤分析 |
| 銷售毛利率 (%) | 36.227 | 40.131 | 43.727 | 46.223 | 52.616 |
| 營業利潤率 (%) | 2.737 | 7.919 | 6.383 | 10.091 | 6.693 |
| 息稅前利潤/營業總收入 (%) | 2.757 | 7.931 | 6.661 | 10.288 | 7.078 |
| 淨利潤/營業總收入 (%) | 1.739 | 6.158 | 5.463 | 8.155 | 3.922 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 80.398 | 100.661 | 108.534 | 107.602 | 111.833 |
| 價值變動淨收益/利潤總額(%) | 1.686 | -0.588 | 0.226 | 0.856 | 5.785 |
| 營業外收支淨額/利潤總額(%) | -4.562 | 0.488 | -0.196 | -2.258 | -6.868 | 償債能力分析 |
| 流動比率 (X) | 1.747 | 1.835 | 1.480 | 1.357 | 1.510 |
| 速動比率 (X) | 1.260 | 1.348 | 1.167 | 1.016 | 1.234 |
| 資產負債率 (%) | 27.692 | 31.630 | 36.088 | 37.192 | 34.800 |
| 帶息債務/全部投入資本 (%) | 10.648 | 14.082 | 16.791 | 16.826 | 15.680 |
| 股東權益/帶息債務 (%) | 800.639 | 580.843 | 471.687 | 469.060 | 506.267 |
| 股東權益/負債合計 (%) | 256.399 | 212.483 | 173.962 | 166.483 | 184.911 |
| 利息保障倍數 (X) | 19.847 | -297.684 | 22.930 | 24.528 | 8.681 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 69.206 | 62.885 | 60.464 | 60.513 | 74.018 |
| 存貨周轉天數 (天) | 123.521 | 98.052 | 97.678 | 92.665 | 81.750 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 13/01/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
